SCHEMBL4060243

SCHEMBL4060243

O=C(N[C@H]1CCc2ccccc21)c1ncc2cccnc2c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 4/20 0.49
TAS1R1 Q7RTX1 4/20 0.49
TAS1R2 Q8TE23 4/20 0.49
P2RX7 Q99572 3/20 0.48
ALDH1A1 P00352 2/20 0.48
TSHR P16473 1/20 0.48
ADORA2A P29274 1/20 0.47
HPGDS O60760 1/20 0.46
PDE2A O00408 1/20 0.45
HTT P42858 1/20 0.44
TAOK1 Q7L7X3 1/20 0.43
TAOK3 Q9H2K8 1/20 0.43
FEN1 P39748 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
ROCK2 O75116 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4066910 1.00 TAS1R3 (0.49) TAS1R3TAS1R1TAS1R2P2RX7ALDH1A1
SCHEMBL4064260 0.94 ALDH1A1 (0.57) TAS1R3TAS1R1TAS1R2P2RX7ALDH1A1
SCHEMBL4062971 0.83 TAS1R3 (0.58) TAS1R3TAS1R1TAS1R2P2RX7ALDH1A1
SCHEMBL4067984 0.82 MTNR1A (0.43) P2RX7TAOK1TAOK3FEN1
SCHEMBL4069001 0.81 FEN1 (0.47) ALDH1A1ADORA2AFEN1NPC1RAB9A
SCHEMBL4071013 0.81 ADORA2A (0.50) TAS1R3TAS1R1TAS1R2P2RX7ALDH1A1
SCHEMBL4061981 0.79 FEN1 (0.44) P2RX7ALDH1A1FEN1NPC1RAB9A
SCHEMBL4061983 0.79 FEN1 (0.44) P2RX7ALDH1A1FEN1NPC1RAB9A
SCHEMBL4061976 0.79 FEN1 (0.44) P2RX7ALDH1A1FEN1NPC1RAB9A
SCHEMBL5583606 0.75 PDE4A (0.59) TAS1R3TAS1R1TAS1R2ADORA2AHPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921759-B2 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK & CO., INC. (US) 2005-07-26 US claimed
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK SHARP & DOHME CORP. 2003-03-20 US claimed
EP-1326865-B1 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2009-05-06 EP disclosed
EP-1326865-B1 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2009-05-06 EP disclosed
US-20050176718-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors ANTHONY NEVILLE J (US) 2005-08-11 US disclosed
US-6921759-B2 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK & CO., INC. (US) 2005-07-26 US disclosed
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK SHARP & DOHME CORP. 2003-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors POLI, DUT, NAAA TAS1R3 4457/4885TAS1R1 4494/4885TAS1R2 4573/4885
US-20050176718-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors POLI, DUT, NAAA TAS1R3 4457/4885TAS1R1 4494/4885TAS1R2 4573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.